Modulation of regulators of cellular pH in Small Cell Lung Cancer cells by chemotherapeutic drugs
Explore this paper's citation graph
- Published
- 2013-01-01
- Cited by
- 1
- References
- 178
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:92504030
References
- Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships.
- Signal transduction pathways in apoptosis.
- Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
- Blood flow, oxygen consumption and tissue oxygenation of human tumors.
- A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
- An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.
- Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes
- Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
- Management of small-cell lung cancer.
- Histological Typing of Lung and Pleural Tumours
- Targeted therapies in small cell lung cancer.
- Induction of protein phosphorylation, protein synthesis, immediate-early-gene expression and cellular proliferation by intracellular pH modulation. Implications for the role of hydrogen ions in signal transduction.
- Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.
- Microinjection of ras p21 induces a rapid rise in intracellular pH
- Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
- Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
- Transcriptional gene expression profiling of small cell lung cancer cells.
- Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
- Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.
- Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.
Cited by
Related papers
No related papers recorded.